Download
journal.pone.0235458.pdf 645,28KB
WeightNameValue
1000 Titel
  • Clinical characteristics of 82 cases of death from COVID-19
1000 Autor/in
  1. Zhang, Bicheng |
  2. Zhou, Xiaoyang |
  3. Qiu, Yanru |
  4. Song, Yuxiao |
  5. Feng, Fan |
  6. Feng, Jia |
  7. Song, Qi Bin |
  8. Jia, Qingzhu |
  9. Wang, Jun |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-07-09
1000 Erschienen in
1000 Quellenangabe
  • 15(7):e0235458
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1371/journal.pone.0235458 |
1000 Ergänzendes Material
  • https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235458#sec012 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • A recently developed pneumonia caused by SARS-CoV-2 bursting in Wuhan, China, has quickly spread across the world. We report the clinical characteristics of 82 cases of death from COVID-19 in a single center. Clinical data on 82 death cases laboratory-confirmed as SARS-CoV-2 infection were obtained from a Wuhan local hospital’s electronic medical records according to previously designed standardized data collection forms. All patients were local residents of Wuhan, and a large proportion of them were diagnosed with severe illness when admitted. Due to the overwhelming of our system, a total of 14 patients (17.1%) were treated in the ICU, 83% of deaths never received Critical Care Support, only 40% had mechanical ventilation support despite 100% needing oxygen and the leading cause of death being pulmonary. Most of the patients who died were male (65.9%). More than half of the patients who died were older than 60 years (80.5%), and the median age was 72.5 years. The bulk of the patients who died had comorbidities (76.8%), including hypertension (56.1%), heart disease (20.7%), diabetes (18.3%), cerebrovascular disease (12.2%), and cancer (7.3%). Respiratory failure remained the leading cause of death (69.5%), followed by sepsis/MOF (28.0%), cardiac failure (14.6%), hemorrhage (6.1%), and renal failure (3.7%). Furthermore, respiratory, cardiac, hemorrhagic, hepatic, and renal damage were found in 100%, 89%, 80.5%, 78.0%, and 31.7% of patients, respectively. On admission, lymphopenia (89.2%), neutrophilia (74.3%), and thrombocytopenia (24.3%) were usually observed. Most patients had a high neutrophil-to-lymphocyte ratio of >5 (94.5%), high systemic immune-inflammation index of >500 (89.2%), and increased C-reactive protein (100%), lactate dehydrogenase (93.2%), and D-dimer (97.1%) levels. A high level of IL-6 (>10 pg/ml) was observed in all detected patients. The median time from initial symptoms to death was 15 days (IQR 11–20), and a significant association between aspartate aminotransferase (p = 0.002), alanine aminotransferase (p = 0.037) and time from initial symptoms to death was remarkably observed. Older males with comorbidities are more likely to develop severe disease and even die from SARS-CoV-2 infection. Respiratory failure is the main cause of COVID-19, but the virus itself and cytokine release syndrome-mediated damage to other organs, including cardiac, renal, hepatic, and hemorrhagic damage, should be taken seriously as well.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Aminotransferases
lokal C-reactive proteins
lokal Lungs
lokal Respiratory failure
lokal Respiratory infections
lokal Total cell counting
lokal Alanine
lokal Blood counts
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/WmhhbmcsIEJpY2hlbmc=|https://frl.publisso.de/adhoc/uri/WmhvdSwgWGlhb3lhbmc=|https://frl.publisso.de/adhoc/uri/UWl1LCBZYW5ydQ==|https://frl.publisso.de/adhoc/uri/U29uZywgWXV4aWFv|https://frl.publisso.de/adhoc/uri/RmVuZywgRmFu|https://frl.publisso.de/adhoc/uri/RmVuZywgSmlh|https://orcid.org/0000-0001-8446-5910|https://frl.publisso.de/adhoc/uri/SmlhLCBRaW5nemh1|https://orcid.org/0000-0003-3941-2507
1000 Label
1000 Förderer
  1. National Natural Science Foundation of China |
  2. Natural Science Foundation of Hubei Province |
  3. Health and Family Planning Commission of Hubei Province |
  4. Fundamental Research Funds for the Central Universities |
1000 Fördernummer
  1. 81272619; 81572875
  2. 2019CFB635
  3. WJ2019M194
  4. -
1000 Förderprogramm
  1. -
  2. -
  3. -
  4. -
1000 Dateien
  1. Clinical characteristics of 82 cases of death from COVID-19
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Natural Science Foundation of China |
    1000 Förderprogramm -
    1000 Fördernummer 81272619; 81572875
  2. 1000 joinedFunding-child
    1000 Förderer Natural Science Foundation of Hubei Province |
    1000 Förderprogramm -
    1000 Fördernummer 2019CFB635
  3. 1000 joinedFunding-child
    1000 Förderer Health and Family Planning Commission of Hubei Province |
    1000 Förderprogramm -
    1000 Fördernummer WJ2019M194
  4. 1000 joinedFunding-child
    1000 Förderer Fundamental Research Funds for the Central Universities |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6421832.rdf
1000 Erstellt am 2020-07-13T13:33:22.898+0200
1000 Erstellt von 122
1000 beschreibt frl:6421832
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet 2020-07-13T13:35:02.955+0200
1000 Objekt bearb. Mon Jul 13 13:34:18 CEST 2020
1000 Vgl. frl:6421832
1000 Oai Id
  1. oai:frl.publisso.de:frl:6421832 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source